स्वास्थ्य देखभाल और रोकथाम जर्नल

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

अमूर्त

Thyroid Pathology in Polycystic Ovary Syndrome

Ana-Maria Dumitrescu, Ruxandra Vatavu, Roxana-Florentina Sufaru, Andrei-Ionut Cucu, Claudia Florida Costea, Victorita Sorodoc1,5, Anca Sava

Introduction: Polycystic ovary syndrome (PCOS) represents a complex endocrine pathology characterized by hyperandrogenism, amenorrhea and multiple ovarian cysts. Often the symptoms begin in adolescence and if not discovered and treated in time, the pathology can lead to serious complications, such as infertility or even cancer, but also many other comorbidities, such as diabetes, dyslipidemia and cardiac artery disease. It may also have influence over the secretion of thyroid hormones.

Material and method: As methods, we conducted a search in international databasis such as PubMed and Thompson ISI in order to identify which thyroid pathology is involved by or in intercorrelation with the PCOS and its implications, thus, laying the basis for a descriptive literature review. We used in our research the following keywords: „thyroid function”, polycystic ovary syndrome”, selecting only up-dated English articles.

Results: Regarding the fact that there is an increase of endocrine pathology, the intercorelation between PCOS and autoimmune thyroiditis (Hashimotoʽs thyroiditis) has become more acknowledged in literature as sharing a dual path. The way they interconnect has not yet been sufficiently elucidated, but both pathologies have similar common features and elements that link one another very closely. Also, women with PCOS are more likely to have subclinical hypothyroidism than controls, suggesting that PCOS might be a risk factor for subclinical hypothyroidism. There are only a few studies in the current literature that discuss the association between Graves' disease and PCOS, many of them being only case reports. But these allow the hypothesis that there may be an etiopathogenetic link between these two pathologies.

Conclusion: Thyroid dysfunctions, in the form of autoimmune thyroiditis, hypothyroidism, or Graves' disease, are relatively frequently diagnosed in women with polycystic ovary syndrome and for this reason, it is recommended that these patients should undergo a screening of thyroid function, which consists of determining the titer of thyroid hormones, specific serum thyroid autoantibodies and a thyroid ultrasound.